Table 3 Medication content in both groups
Types of medicines | PG (n = 8) | CG (n = 8) | P values |
|---|---|---|---|
Antihypertensives | Â | Â | Â |
 Calcium blocker | 3 | 5 | 0.317 |
α blocker | 0 | 1 | 0.302 |
β blocker | 1 | 1 | 1.000 |
ARB | 3 | 3 | 1.000 |
Diuretics | 2 | 1 | 0.522 |
Antithromboembolism | Â | Â | Â |
 Anticoagulants | 2 | 1 | 0.522 |
 Antiplatelet agents | 5 | 6 | 0.590 |
Antithyperlipidemia (HMG-CoA reductase inhibitor) | Â | Â | Â |
|  | 5 | 5 |  1.000 |
Antidiabetic drug | Â | Â | Â |
| Â | 2 | 0 | Â 0.131 |
Osteoporosis drug (an analogue of vitamin D) | Â | Â | Â |
| Â | 5 | 4 | Â 0.614 |
Analgesics | Â | Â | Â |
 NSAIDs | 0 | 2 | 0.131 |
 Pregabalin | 2 | 2 | 1.000 |
Antidepressant | Â | Â | Â |
 SNRI | 0 | 1 | 0.302 |
 SSRI | 1 | 1 | 1.000 |
 Nonbenzodiazepine | 1 | 1 | 1.000 |
 Benzodiazepine | 1 | 3 | 0.248 |
Gastric secretion inhibitor/ mucosal defense | Â | Â | Â |
 Proton pump inhibitor | 6 | 3 | 0.131 |
 H2 receptor antagonist | 0 | 2 | 0.131 |
 Gastric mucosal defense | 0 | 3 | 0.055 |
Cardiorespiratory disease drugs | Â | Â | Â |
 Bronchodilator (β agonist) | 0 | 1 | 0.302 |
 Antitussive | 0 | 1 | 0.302 |
 Anti-allergic (antihistamine) | 1 | 0 | 0.302 |
 Digitalis | 1 | 0 | 0.302 |
Urologic disease drugs | Â | Â | Â |
 Anticholinergic agent | 1 | 0 | 0.302 |
 β3 agonist | 0 | 1 | 0.302 |
 Urinary tract antispasmodic | 0 | 1 | 0.302 |
Others | Â | Â | Â |
 Laxative | 3 | 3 | 1.000 |
 Thyroid hormone preparation | 1 | 0 | 0.302 |
 Antihyperuricemic | 1 | 1 | 1.000 |
 Acetylcholinesterase inhibitor | 1 | 1 | 1.000 |